169 related articles for article (PubMed ID: 30248343)
1. Radical Prostatectomy after Vascular Targeted Photodynamic Therapy with Padeliporfin: Feasibility, and Early and Intermediate Results.
Pierrard V; Lebdai S; Kleinclauss F; Azzouzi AR; Terrier JE; Fortier E; Joniau S; Van Der Poel H; Salomon G; Casanova J; Medina-Lopez RA; Potiron E; Rigaud J; Vincendeau S; Rassweiler J; Villers A; Gaston R; Saussine C; Giai J; Gaillac B; Emberton M; Ruffion A
J Urol; 2019 Feb; 201(2):315-321. PubMed ID: 30248343
[TBL] [Abstract][Full Text] [Related]
2. Feasibility, safety, and efficacy of salvage radical prostatectomy after Tookad® Soluble focal treatment for localized prostate cancer.
Lebdai S; Villers A; Barret E; Nedelcu C; Bigot P; Azzouzi AR
World J Urol; 2015 Jul; 33(7):965-71. PubMed ID: 25614256
[TBL] [Abstract][Full Text] [Related]
3. Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches.
Gontero P; Marra G; Alessio P; Filippini C; Oderda M; Munoz F; Linares E; Sanchez-Salas R; Challacombe B; Dasgupta P; Goonewardene S; Popert R; Cahill D; Gillatt D; Persad R; Palou J; Joniau S; Piechaud T; Morlacco A; Vidit S; Rouprêt M; De La Taille A; Albisinni S; Gandaglia G; Mottrie A; Joshi S; Fiscus G; Berger A; Aron M; Van Der Poel H; Tilki D; Lawrentschuk N; Murphy DG; Leung G; Davis J; Karnes RJ;
J Urol; 2019 Oct; 202(4):725-731. PubMed ID: 31075058
[TBL] [Abstract][Full Text] [Related]
4. Preliminary analysis of the feasibility and safety of salvage robot-assisted radical prostatectomy after radiation failure: multi-institutional perioperative and short-term functional outcomes.
Chauhan S; Patel MB; Coelho R; Liss M; Rocco B; Sivaraman AK; Palmer KJ; Coughlin GD; Ferrigni RG; Castle EP; Ahlering TE; Parra-Davila E; Patel VR
J Endourol; 2011 Jun; 25(6):1013-9. PubMed ID: 21568696
[TBL] [Abstract][Full Text] [Related]
5. Vascular Targeted Photodynamic Therapy with Padeliporfin for Low Risk Prostate Cancer Treatment: Midterm Oncologic Outcomes.
Lebdai S; Bigot P; Leroux PA; Berthelot LP; Maulaz P; Azzouzi AR
J Urol; 2017 Aug; 198(2):335-344. PubMed ID: 28322857
[TBL] [Abstract][Full Text] [Related]
6. Early Experience with Salvage Retzius-sparing Robotic-assisted Radical Prostatectomy: Oncologic and Functional Outcomes.
Madi R; Sayyid RK; Hiffa A; Thomas E; Terris MK; Klaassen Z
Urology; 2021 Mar; 149():117-121. PubMed ID: 33417926
[TBL] [Abstract][Full Text] [Related]
7. Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials).
Noweski A; Roosen A; Lebdai S; Barret E; Emberton M; Benzaghou F; Apfelbeck M; Gaillac B; Gratzke C; Stief C; Azzouzi AR
Eur Urol Focus; 2019 Nov; 5(6):1022-1028. PubMed ID: 29661587
[TBL] [Abstract][Full Text] [Related]
8. [Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results].
Vidmar R; Marcq G; Flamand V; Fantoni JC; Hénon F; Villers A; Ouzzane A
Prog Urol; 2017; 27(8-9):458-466. PubMed ID: 28576424
[TBL] [Abstract][Full Text] [Related]
9. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.
Trachtenberg J; Bogaards A; Weersink RA; Haider MA; Evans A; McCluskey SA; Scherz A; Gertner MR; Yue C; Appu S; Aprikian A; Savard J; Wilson BC; Elhilali M
J Urol; 2007 Nov; 178(5):1974-9; discussion 1979. PubMed ID: 17869307
[TBL] [Abstract][Full Text] [Related]
10. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
11. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.
Azzouzi AR; Vincendeau S; Barret E; Cicco A; Kleinclauss F; van der Poel HG; Stief CG; Rassweiler J; Salomon G; Solsona E; Alcaraz A; Tammela TT; Rosario DJ; Gomez-Veiga F; Ahlgren G; Benzaghou F; Gaillac B; Amzal B; Debruyne FM; Fromont G; Gratzke C; Emberton M;
Lancet Oncol; 2017 Feb; 18(2):181-191. PubMed ID: 28007457
[TBL] [Abstract][Full Text] [Related]
12. Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial.
Sooriakumaran P; Pini G; Nyberg T; Derogar M; Carlsson S; Stranne J; Bjartell A; Hugosson J; Steineck G; Wiklund PN
Eur Urol; 2018 Apr; 73(4):618-627. PubMed ID: 28882327
[TBL] [Abstract][Full Text] [Related]
13. Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline.
Pompe RS; Karakiewicz PI; Tian Z; Mandel P; Steuber T; Schlomm T; Salomon G; Graefen M; Huland H; Tilki D
J Urol; 2017 Aug; 198(2):354-361. PubMed ID: 28216329
[TBL] [Abstract][Full Text] [Related]
14. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
15. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
16. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited.
Vaidya A; Soloway MS
J Urol; 2000 Dec; 164(6):1998-2001. PubMed ID: 11061900
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic extraperitoneal radical prostatectomy: oncological and functional results after 700 procedures.
Stolzenburg JU; Rabenalt R; DO M; Ho K; Dorschner W; Waldkirch E; Jonas U; Schütz A; Horn L; Truss MC
J Urol; 2005 Oct; 174(4 Pt 1):1271-5; discussion 1275. PubMed ID: 16145391
[TBL] [Abstract][Full Text] [Related]
18. Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer.
Lawrentschuk N; Finelli A; Van der Kwast TH; Ryan P; Bolton DM; Fleshner NE; Trachtenberg J; Klotz L; Robinette M; Woo H
J Urol; 2011 Mar; 185(3):862-8. PubMed ID: 21239003
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of salvage radical prostatectomy following more than one failed local therapy.
Sivaraman A; Scardino P; Eastham J
Investig Clin Urol; 2018 May; 59(3):152-157. PubMed ID: 29744471
[TBL] [Abstract][Full Text] [Related]
20. TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.
Azzouzi AR; Barret E; Moore CM; Villers A; Allen C; Scherz A; Muir G; de Wildt M; Barber NJ; Lebdai S; Emberton M
BJU Int; 2013 Oct; 112(6):766-74. PubMed ID: 24028764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
